| Joseph A Sanchez, LPC | |
|
1115 Elkton Dr Ste 300, Colorado Springs, CO 80907-3597 | |
| (719) 373-9703 | |
| (877) 588-3465 |
| Full Name | Joseph A Sanchez |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 1115 Elkton Dr Ste 300, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770897019 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 11425 (Colorado) | Secondary |
| 101YP2500X | Counselor - Professional | LPC.0011425 (Colorado) | Primary |
| Entity Name | Achieve Whole Recovery, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013456383 PECOS PAC ID: 8123388527 Enrollment ID: O20180202001959 |
News Archive
Primordial, a leading vendor of communications, workflow, quality management and analytics applications for the medical imaging market, and Charlotte Radiology, one of the largest radiology groups in the United States, announced today a partnership to deploy and further develop Primordial's applications for use by Charlotte Radiology physicians across numerous hospitals and imaging centers.
AstraZeneca today announced preliminary efficacy and safety data for AZD9291 in the first-line treatment of epidermal growth factor receptor mutation positive (EGFRm) advanced non-small cell lung cancer (NSCLC).
The 'Xpert Ultra' molecular test has a greater capacity than its predecessor ('Xpert MTB/RIF') in detecting tuberculosis cases, either passively (i.e. people who attend the hospital with disease symptoms) or actively (searching for possible cases in the community among contacts of cases).
Currently, opioids are the standard treatment for chronic pain. Patients on opioids for long periods of time become desensitized to these drugs or become paradoxically hypersensitive to pain (hyperalgesia); however, the adaptive mechanisms are not well understood.
Civitas Therapeutics, Inc., a privately held biopharmaceutical company focused on developing transformative pulmonary delivery therapies, announced today that it has secured a $20 million Series A financing from founding investor, Longitude Capital, along with co-lead Canaan Partners. The proceeds of the financing will be primarily used to advance Civitas' lead program for treating patients with Parkinson's disease through clinical proof-of-concept.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph A Sanchez, LPC 11173 Indian Echo Ter, Peyton, CO 80831-7095 Ph: (719) 338-9403 | Joseph A Sanchez, LPC 1115 Elkton Dr Ste 300, Colorado Springs, CO 80907-3597 Ph: (719) 373-9703 |
News Archive
Primordial, a leading vendor of communications, workflow, quality management and analytics applications for the medical imaging market, and Charlotte Radiology, one of the largest radiology groups in the United States, announced today a partnership to deploy and further develop Primordial's applications for use by Charlotte Radiology physicians across numerous hospitals and imaging centers.
AstraZeneca today announced preliminary efficacy and safety data for AZD9291 in the first-line treatment of epidermal growth factor receptor mutation positive (EGFRm) advanced non-small cell lung cancer (NSCLC).
The 'Xpert Ultra' molecular test has a greater capacity than its predecessor ('Xpert MTB/RIF') in detecting tuberculosis cases, either passively (i.e. people who attend the hospital with disease symptoms) or actively (searching for possible cases in the community among contacts of cases).
Currently, opioids are the standard treatment for chronic pain. Patients on opioids for long periods of time become desensitized to these drugs or become paradoxically hypersensitive to pain (hyperalgesia); however, the adaptive mechanisms are not well understood.
Civitas Therapeutics, Inc., a privately held biopharmaceutical company focused on developing transformative pulmonary delivery therapies, announced today that it has secured a $20 million Series A financing from founding investor, Longitude Capital, along with co-lead Canaan Partners. The proceeds of the financing will be primarily used to advance Civitas' lead program for treating patients with Parkinson's disease through clinical proof-of-concept.
› Verified 7 days ago
Elizabeth Anne Beck, LPC CAC III Counselor Medicare: Not Enrolled in Medicare Practice Location: 2790 N Academy Blvd, Suite 206, Colorado Springs, CO 80917 Phone: 719-596-1530 Fax: 719-559-1130 | |
Andrea Wood, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 435 Gold Pass Hts, Colorado Springs, CO 80906 Phone: 719-205-2671 Fax: 719-632-2342 | |
Norma Dejesus, Counselor Medicare: Not Enrolled in Medicare Practice Location: 179 Parkside Dr, Colorado Springs, CO 80910 Phone: 719-572-6300 | |
Sheila Kelly, Counselor Medicare: Not Enrolled in Medicare Practice Location: 115 Parkside Dr, Colorado Springs, CO 80910 Phone: 719-572-6340 | |
Robert B. Wenzel, M.A. LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4360 Montebello Dr Ste 400, Colorado Springs, CO 80918 Phone: 719-593-9228 Fax: 719-598-1705 | |
Dawn Zink, MA LPC NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4975 Austin Bluffs Pkwy, Colorado Springs, CO 80918 Phone: 719-301-5488 | |
Melissa Beth Smart, LPC Counselor Medicare: Medicare Enrolled Practice Location: 1330 Inverness Dr Ste 400, Colorado Springs, CO 80910 Phone: 970-310-3406 |